Basic Information
| LncRNA/CircRNA Name | LINC00663 |
| Synonyms | NA |
| Region | GRCh38_19:19757366-19776423 |
| Ensemble | ENSG00000266904 |
| Refseq | NR_026956 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR etc. |
| Sample | cell lines (DU-145 and PC3) |
| Expression Pattern | down-regulated |
| Function Description | Additionally, LINC00663 was shown to be expressed at low levels in DU-145 and PC3 prostate cancer, HGC-27 stomach carcinoma, CRL-1469 pancreatic carcinoma, A549 lung cancer, MCF7 breast cancer, and BCPAP thyroid cancer cell lines |
| Pubmed ID | 26743782 |
| Year | 2016 |
| Title | A novel variable exonic region and differential expression of LINC00663 non-coding RNA in various cancer cell lines and normal human tissue samples. |
External Links
| Links for LINC00663 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |